delivery-platform
(2)
Aera Therapeutics
Aera Therapeutics is a Cambridge, Massachusetts biotech founded on a discovery from CRISPR pioneer Feng Zhang: human proteins that can self-assemble into capsid-like shells and ferry genetic cargo into cells. The company is building delivery platforms - protein nanoparticles, targeted lipid nanoparticles, and antibody-oligonucleotide conjugates - to solve the field's most stubborn problem: getting genetic medicines to the right tissue. Launched publicly in 2023 with $193M and led by Alnylam veteran Akin Akinc, Aera is betting that delivery, not the drug itself, is the bottleneck holding back the next generation of genetic medicine.
Nash
Nash is the operating platform for last-mile logistics. It unifies delivery operations into one orchestration layer that lets enterprise merchants, marketplaces, and platforms route, dispatch, and track every order across internal fleets, 3PLs, and a network of 1,000+ delivery providers in 15+ countries. Founded in 2021 and backed by a16z and Y Combinator, Nash now powers deliveries for Walmart, Grubhub, Woolworths, 7-Eleven, Square, and Urban Outfitters.